From artificial intelligence to autonomous sterilization robots to drones, emerging technologies are playing a strong role in combating COVID-19.
Recalls for failure are chronic in the medical device industry. The sources of those failures could originate anywhere in the supply chain. Fixing supply chain issues is ultimately the responsibility of the instrument’s maker.
The self-driving UV disinfection robots are being sent to more than 2000 hospitals.
During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.
Innovation requires the space for failure and continuous improvement.
The two-day event takes place September 22–23, 2020. Submit an abstract, or register to attend.
For medical device manufacturers, the American Invents Act created several challenges related to patent marking.
The enforcement operation kept nearly 500 shipments of illegal drugs and combination devices from the hands of consumers.